Market Research Logo

Cocrystal Pharma, Inc. - Product Pipeline Review - 2016

Cocrystal Pharma, Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Cocrystal Pharma, Inc. - Product Pipeline Review - 2016’, provides an overview of the Cocrystal Pharma, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Cocrystal Pharma, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Cocrystal Pharma, Inc.
  • The report provides overview of Cocrystal Pharma, Inc. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Cocrystal Pharma, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Cocrystal Pharma, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Cocrystal Pharma, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Cocrystal Pharma, Inc.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Cocrystal Pharma, Inc.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Cocrystal Pharma, Inc. Snapshot
Cocrystal Pharma, Inc. Overview
Key Information
Key Facts
Cocrystal Pharma, Inc. - Research and Development Overview
Key Therapeutic Areas
Cocrystal Pharma, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Cocrystal Pharma, Inc. - Pipeline Products Glance
Cocrystal Pharma, Inc. - Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
Cocrystal Pharma, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Cocrystal Pharma, Inc. - Drug Profiles
CC-31244
Product Description
Mechanism of Action
R&D Progress
CC-1845
Product Description
Mechanism of Action
R&D Progress
CC-2068
Product Description
Mechanism of Action
R&D Progress
CC-2069
Product Description
Mechanism of Action
R&D Progress
CDI-244
Product Description
Mechanism of Action
R&D Progress
Gene Therapy for Hepatitis B and Human Papilloma Virus Infections
Product Description
Mechanism of Action
R&D Progress
CC-31326
Product Description
Mechanism of Action
R&D Progress
RS-1137
Product Description
Mechanism of Action
R&D Progress
RS-1142
Product Description
Mechanism of Action
R&D Progress
RS-1145
Product Description
Mechanism of Action
R&D Progress
RS-930
Product Description
Mechanism of Action
R&D Progress
RS-961
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Hepatitis C
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit PB2 for Influenza
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit RNA Dependent RNA Polymerase for Common Cold
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit RNA Dependent RNA Polymerase for Dengue Virus Infections
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit RNA Dependent RNA Polymerase for Norovirus Infections
Product Description
Mechanism of Action
R&D Progress
Cocrystal Pharma, Inc. - Pipeline Analysis
Cocrystal Pharma, Inc. - Pipeline Products by Target
Cocrystal Pharma, Inc. - Pipeline Products by Route of Administration
Cocrystal Pharma, Inc. - Pipeline Products by Molecule Type
Cocrystal Pharma, Inc. - Pipeline Products by Mechanism of Action
Cocrystal Pharma, Inc. - Recent Pipeline Updates
Cocrystal Pharma, Inc. - Dormant Projects
Cocrystal Pharma, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Cocrystal Pharma, Inc., Key Information
Cocrystal Pharma, Inc., Key Facts
Cocrystal Pharma, Inc. - Pipeline by Indication, 2016
Cocrystal Pharma, Inc. - Pipeline by Stage of Development, 2016
Cocrystal Pharma, Inc. - Monotherapy Products in Pipeline, 2016
Cocrystal Pharma, Inc. - Out-Licensed Products in Pipeline, 2016
Cocrystal Pharma, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2016
Cocrystal Pharma, Inc. - Phase I, 2016
Cocrystal Pharma, Inc. - Preclinical, 2016
Cocrystal Pharma, Inc. - Discovery, 2016
Cocrystal Pharma, Inc. - Pipeline by Target, 2016
Cocrystal Pharma, Inc. - Pipeline by Route of Administration, 2016
Cocrystal Pharma, Inc. - Pipeline by Molecule Type, 2016
Cocrystal Pharma, Inc. - Pipeline Products by Mechanism of Action, 2016
Cocrystal Pharma, Inc. - Recent Pipeline Updates, 2016
Cocrystal Pharma, Inc. - Dormant Developmental Projects,2016
Cocrystal Pharma, Inc., Other Locations
List of Figures
Cocrystal Pharma, Inc. - Pipeline by Indication, 2016
Cocrystal Pharma, Inc. - Pipeline by Stage of Development, 2016
Cocrystal Pharma, Inc. - Monotherapy Products in Pipeline, 2016
Cocrystal Pharma, Inc. - Pipeline by Target, 2016
Cocrystal Pharma, Inc. - Pipeline by Route of Administration, 2016
Cocrystal Pharma, Inc. - Pipeline by Molecule Type, 2016
Cocrystal Pharma, Inc. - Pipeline Products by Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report